Category: Publications

COVID-19 Antibody in Thai Community Hospitals

COVID-19 seroprevalence data has been scarce, especially in less developed countries with a relatively low infection rate.

26. June 2020

Seroprevalence of SARS-CoV-2 IgG Specific Antibodies among Healthcare Workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave

The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) around the world has caused a global pandemic, infecting millions of individuals worldwide, with an unprecedented impact in health care systems worldwide.

26. June 2020

Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA).

Castiglione D’Adda is one of the towns earlier and more severely affected by the SARS-CoV-2 epidemic in Lombardy.

24. June 2020

A primary care approach to the COVID-19 pandemic: clinical features and natural history of 2,073 suspected cases in the Corona Sao Caetano programme, Sao Paulo, Brazil

Despite most cases not requiring hospital care, there are limited community-based clinical data on COVID-19.

23. June 2020

Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19

Greece is a country with limited spread of SARS-CoV-2 and cumulative infection attack rate of 0.12% (95%CI 0.06%-0.26%).

23. June 2020

SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers

SARS-CoV-2 may pose an occupational health risk to health care workers, but the prevalence of infections in this population is unknown.

23. June 2020

First results from the UK COVID-19 Serology in Oncology Staff Study (CSOS)

The global SARS-CoV-2 (COVID-19) pandemic has caused substantial worldwide mortality.

23. June 2020

SEROPREVALENCE AND CLINICAL SPECTRUM OF SARS-CoV-2 INFECTION IN THE FIRST VERSUS THIRD TRIMESTER OF PREGNANCY

Case registries of pregnant women diagnosed with coronavirus disease (COVID-19) by polymerase chain reaction (PCR) have reported that the majority experienced mild infection, but up to 9% may require critical care.

19. June 2020

Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China

The seroprevalence of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a more reliable approach to detect true infected population, particularly in asymptomatic persons.

19. June 2020

Seroprevalence of Antibodies to SARS-CoV-2 in Healthcare Workers in Non-epidemic Region: A Report from Iwate Prefecture in Japan

As of June 18, 2020, Iwate is the only one of 47 prefectures in Japan with no confirmed coronavirus disease 2019 (COVID-19) cases.

17. June 2020

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Plattform for seroprevalence studies on SARS-COV-2

Privacy Policy
Impress